Liposuction Device Adverse Events: What 526 FDA MAUDE Reports Reveal

Liposuction is the original body-contouring procedure, and the public conversation about its risk usually focuses on the surgeon's hands. But liposuction is also one of the most device-dependent procedures in aesthetic medicine — suction pumps, cannulas, powered handpieces, ultrasound probes, radiofrequency electrodes, and fat-processing systems all sit between the surgeon and the patient. The short answer to the question this data answers: when a liposuction device itself is implicated in an FDA adverse-event report, the report splits almost evenly between a patient injury and a device malfunction, ultrasound-assisted (VASER) systems dominate the reports, and the characteristic device-attributable injury is a burn — thermal or friction — at the probe or port site.

This article walks through an analysis of public MAUDE records naming suction-lipectomy and lipoplasty devices, what the device-level failure patterns look like, how they fit with the published clinical evidence on ultrasound- and power-assisted liposuction, and what to ask before a procedure. It is educational, not a diagnosis. Signs of a complication after liposuction — spreading redness, fever, severe or asymmetric swelling, skin color changes, or breathing problems — should be evaluated by a clinician immediately.

How liposuction devices differ — and why it matters for what fails

"Suction-assisted lipectomy" is the baseline: a hollow cannula attached to a vacuum that physically removes fat. Around it, manufacturers have layered energy and powered adjuncts that change both the patient experience and the failure modes:

• Power-assisted liposuction (PAL) — a motorized cannula that vibrates (e.g., MicroAire's systems). The moving part that fails is the handpiece motor and cannula drive.
• Ultrasound-assisted liposuction (UAL) — an ultrasonic probe emulsifies fat before suction (e.g., VASERlipo, made by Solta Medical). The energy-delivering probe is also the part that can burn tissue.
• Radiofrequency-assisted liposuction (RFAL) — an internal RF electrode melts fat and tightens skin (e.g., BodyTite). RF carries pacemaker contraindications and its own thermal-injury profile.
• Fat-transfer processing — lipoaspirate washing and collection systems (e.g., Revolve) that prepare removed fat for reinjection, linking liposuction to gluteal fat grafting.

Each of these maps to specific FDA device product codes, which is what makes a device-level analysis possible.

What 526 MAUDE reports reveal

The FDA's MAUDE database (Manufacturer and User Facility Device Experience) is a passive-surveillance system. It collects voluntary reports from patients and providers, mandatory reports from manufacturers, and facility reports. It cannot be used to calculate how often something happens in the real world, it underreports heavily, and a report that a problem followed a procedure is not proof the device caused it. With those caveats, it is the closest thing to a public ledger of what goes wrong with specific devices.

An analysis of public MAUDE records under the FDA product codes for suction-lipectomy and lipoplasty systems — MUU (suction lipoplasty system), QPB (suction lipoplasty for removal), and QKL (lipoaspirate washing system) — found 526 unique reports received between 2010 and early 2026. The breakdowns are striking in what they emphasize:

Two things stand out. First, injuries and malfunctions are nearly balanced — unlike aesthetic energy devices such as cryolipolysis or lasers, where injury reports dominate, liposuction-device reports are split roughly half between a patient harmed and a device that simply stopped working or performed incorrectly. Second, the system is overwhelmingly manufacturer-driven (89% of reports), which reflects the mandatory-reporting obligations on device firms rather than a wave of patient complaints.

Which devices concentrate the reports

The reports are not spread evenly across manufacturers. VASERlipo — Solta Medical's ultrasound-assisted system — is the single most-named device family:

The dominance of VASER is consistent with ultrasound-assisted liposuction being the most device-intensive variant of the procedure: it adds an ultrasonic probe, a generator, and specialized cannulas to the basic suction setup, which adds both malfunction surfaces and a thermal-injury mechanism that pure suction lipectomy does not have. The 74 reports generic-coded to "fat transfer" connect this device set directly to fat-grafting procedures.

The reporting trend

Reports rose steadily across the period and concentrated in the most recent five years. As with every MAUDE trend, this reflects reporting behavior and device adoption as much as any true change in safety — but it does show the device base is large, active, and under continued manufacturer surveillance.

What actually goes wrong: burns, probes, and aspiration

Read against the device mix, the failure patterns line up with how each technology works:

• Thermal and friction burns at the probe or port site are the signature device-attributable injury of ultrasound- and radiofrequency-assisted liposuction. The VASER probe vibrates and can cause a friction burn where it meets skin; RF-assisted devices (BodyTite) deliver heat that can cause a thermal burn. Standard technique protects the skin entry point with plastic ports and tumescence fluid, and most reported burns trace to a port that slipped, insufficient tumescence, or a probe touching unprotected skin.
• Handpiece and probe malfunctions dominate the power-assisted and ultrasound reports — cracked probes, motorized cannulas that stalled, generators that errored mid-procedure. These are the "device malfunction" half of the ledger.
• Aspirator and suction failures — pumps that lost vacuum, flow that dropped, collection canisters that failed — appear under the PSI-TEC and generic suction-system brands.
• Fat-processing system issues appear under the lipoaspirate-wash codes, tying back to fat-transfer workflows where processed fat is reinjected.

How this fits the clinical evidence

Device-level reports describe what goes wrong; they do not measure how often it goes wrong. The published clinical literature on ultrasound-assisted liposuction, where the device signal concentrates, gives the denominator. VASER received FDA clearance for use in liposuction in 2002. A consensus paper on VASER UAL published in the peer-reviewed literature notes that, relative to traditional suction lipectomy, side effects such as bruising and pain are less severe and shorter in duration. Large case series report overall complication rates in the low single digits — one 660-patient UAL series reported a 1.9% complication rate with zero severe adverse events, and a 261-case series reported a 4.6% overall complication rate (contour irregularity 1.9%, seroma 0.8%, cellulitis 0.8%). A 306-patient series documented 20 seromas, 9 port-site burns, and 5 cases of prolonged edema.

Those numbers describe what careful, high-volume practice looks like. The MAUDE reports describe the tail — the cases where a device, a setting, or a technique diverged from that standard.

For context, the broader liposuction literature places overall complication rates in the 8.6–20% range (contour irregularity is the most common, reported in roughly 20% of cases in some series), with major or life-threatening complications — skin necrosis, infection, necrotizing fasciitis, pulmonary embolism, and fatal outcomes — documented in approximately 0.02–0.25% of cases. The rare but serious systemic risks of liposuction are fat embolism, venous thromboembolism, fluid overload, and perforation. These are procedure risks more than device-specific ones, but they are the reason the two deaths in the device MAUDE data demand interpretation rather than dismissal, and the reason liposuction belongs in an accredited facility with appropriate monitoring regardless of which device is on the cart.

Candidacy and the patient who is not a fit

Liposuction is not a weight-loss procedure. Manufacturers of ultrasound-assisted systems list contraindications that include obesity, diabetes, clotting disorders, cardiovascular and vascular disease, connective-tissue and scarring disorders, lupus, endocrine disorders, and pregnancy. Radiofrequency-assisted devices add a hard contraindication: they are not compatible with pacemakers, because the RF current interferes with the device. Patients with a pacemaker or implantable defibrillator should not receive RF-assisted liposuction. Patients with significant skin laxity in the treated area may be better served by an excisional procedure, because removing fat without tightening loose skin can worsen sagging.

What to ask a provider

• What device are you using, and why? Suction-only, power-assisted, ultrasound-assisted, and RF-assisted liposuction have different downtime, skin-tightening effects, and device-specific risks. "Liposuction" is not one procedure.
• How do you prevent port-site and probe burns? The answer should mention skin-protecting ports, adequate tumescence, and probe technique. This is the most preventable device-related injury.
• Is the device appropriate for my anatomy and any implants? Specifically, RF-assisted devices and pacemakers do not mix.
• What is your complication plan? Seroma, contour irregularity, burns, and — rarely — more serious events are recognized risks of liposuction regardless of device.

Liposuction is safe in the hands of a trained, credentialed provider using maintained equipment. The device reports describe the cases where that standard slipped — a burned port site, a probe that fractured, an aspirator that failed mid-case. Understanding the device behind the procedure turns a vague fear of "something going wrong" into a specific set of questions a patient can actually ask.

Sources

• U.S. FDA, MAUDE (Manufacturer and User Facility Device Experience) public database — analysis of suction-lipectomy and lipoplasty device reports under product codes MUU, QPB, and QKL, 2010 – early 2026 (run June 2026): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm
• U.S. FDA, 510(k) clearance database — lipoplasty system clearances (product codes MUU, QPB): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm
• Consensus-based recommendations for VASER ultrasound-assisted liposuction, Plastic and Reconstructive Surgery – Global Open (PMC10335824), including FDA clearance year (2002) and safety profile relative to suction-assisted lipectomy: https://pmc.ncbi.nlm.nih.gov/articles/PMC10335824
• Safety and efficacy of third-generation ultrasound-assisted liposuction (case-series complication rates: 1.9% in 660 UAL patients; 4.6% in 261 cases; 306-patient series), Asaadi Plastic Surgery: https://www.asaadiplasticsurgery.com/media/PDFs/Safety-and-Efficacy-of-Third-Generation-Ultrasound-Assisted-Liposuction.pdf
• VASERlipo important safety information and contraindications (Solta Medical), including thermal-burn risks and RF/pacemaker considerations: https://www.vaser.com
• Evaluation of postoperative complications in VASER-assisted liposuction, Namık Kemal Medical Journal 2024 (overall liposuction complication rates 8.6–20%; major/life-threatening complications ~0.02–0.25%; contour deformity ~20%): https://namikkemalmedj.com/pdf/4615d177-864c-42ed-adf7-32226220a22b/articles/nkmj.galenos.2024.59354/nkmj-12-61-En.pdf